Pharmacokinetics and Safety of Topical Administration of Brimonidine Tartrate Ophthalmic Solution 0.025%.

NCT02039765 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperemia

Interventions

DRUG: Brimonidine tartrate

Sponsor

Bausch & Lomb Incorporated

Collaborators

[object Object]